US Stock MarketDetailed Quotes
IBIO iBio Inc
- 2.5600
- -0.0800-3.03%
Close Nov 25 16:00 ET
23.42MMarket Cap-1185P/E (TTM)
2.7400High2.4600Low148.86KVolume2.6900Open2.6400Pre Close388.58KTurnover1.85%Turnover RatioLossP/E (Static)9.15MShares4.980052wk High1.32P/B20.63MFloat Cap1.021452wk Low--Dividend TTM8.06MShs Float30300.0000Historical High--Div YieldTTM10.61%Amplitude1.0214Historical Low2.6100Avg Price1Lot Size
About iBio Inc Company
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.
Company Profile
SymbolIBIO
Company NameiBio Inc
Listing DateJan 4, 2011
Founded1993
CEODr. Martin B. Brenner, PhD
MarketAMEX
Employees16
Fiscal Year Ends06-30
Address11750 Sorrento Valley Road,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-979-446-0027
Websitehttp://www.ibioinc.com
Company Executives
- Name
- Position
- Salary
- Dr. Martin B. Brenner, PhD
- Director, Chief Executive Officer and Chief Scientific Officer
- 1.27M
- Felipe Duran
- Chief Financial Officer and Principal Accounting Officer
- 761.87K
- William D. Clark
- Chairman of the Board
- 89.08K
- David A. Arkowitz, M.B.A.
- Independent Director
- --
- General James T. Hill, (Ret.)
- Independent Director
- 55.00K
- Gary L. Sender
- Independent Director
- 66.00K
- Evert B. Schimmelpennink
- Independent Director
- 56.67K
- Antonio Parada
- Independent Director
- --
- Dr. Alexandra Kropotova, M.D.
- Independent Director
- 52.50K
- Marc Banjak
- Chief Legal Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data